Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain

被引:144
作者
Lee, KY [1 ]
Clark, AW
Rosales, JL
Chapman, K
Fung, T
Johnston, RN
机构
[1] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Pathol & Clin Neurosci, Calgary, AB T2N 4N1, Canada
[3] Univ Calgary, Neurosci Res Grp, Calgary, AB T2N 4N1, Canada
[4] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada
[5] Univ Calgary, Ctr Comp, Calgary, AB T2N 4N1, Canada
关键词
Alzheimer's disease; neurofibrillary tangles; paired helical filaments; tau phosphorylation; cyclin-dependent kinase; cdk5;
D O I
10.1016/S0168-0102(99)00026-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurofibrillary tangles (NFT) in Alzheimer's disease (AD) consist largely of hyperphosphorylated tau protein. Many of the phosphorylation sites on tau are serine/threonine-proline sequences, several of which are phosphorylated in vitro by neuronal Cdc2-like kinase (Nclk), a kinase composed of Cdk5 and its activator(s). Thus, tau hyperphosphorylation in AD may result in part from deregulation of Ndlk. To test this hypothesis, we examined Nclk activity in prefrontal and cerebellar cortex from 15 postmortem AD and 16 age-matched control subjects, and corrected either for Cdk5 level or for neuronal loss. The ratio of Nclk activity in prefrontal versus cerebellar cortex was then compared. When corrections were made for neuronal loss, the ratios of kinase activity in prefrontal versus cerebellar cortex were significantly higher in AD (6.45 +/- 0.86) than the controls (3.13 +/- 0.46; P = 0.003). This finding is consistent with a role for Nclk in the pathogenesis of NFT in AD. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 56 条
[1]  
BAUDIER J, 1987, J BIOL CHEM, V262, P17577
[2]   ABNORMAL ALZHEIMER-LIKE PHOSPHORYLATION OF TAU-PROTEIN BY CYCLIN-DEPENDENT KINASES CDK2 AND CDK5 [J].
BAUMANN, K ;
MANDELKOW, EM ;
BIERNAT, J ;
PIWNICAWORMS, H ;
MANDELKOW, E .
FEBS LETTERS, 1993, 336 (03) :417-424
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   MITOGEN ACTIVATED PROTEIN (MAP) KINASE TRANSFORMS TAU-PROTEIN INTO AN ALZHEIMER-LIKE STATE [J].
DREWES, G ;
LICHTENBERGKRAAG, B ;
DORING, F ;
MANDELKOW, EM ;
BIERNAT, J ;
GORIS, J ;
DOREE, M ;
MANDELKOW, E .
EMBO JOURNAL, 1992, 11 (06) :2131-2138
[5]   Neurodegenerative disorders with extensive tau pathology: A comparative study and review [J].
Feany, MB ;
Dickson, DW .
ANNALS OF NEUROLOGY, 1996, 40 (02) :139-148
[6]  
GOEDERT M, 1995, NEUROBIOL AGING, V16, P326
[7]  
GONG CX, 1994, J NEUROCHEM, V62, P803
[8]   PHOSPHOPROTEIN PHOSPHATASE-ACTIVITIES IN ALZHEIMER-DISEASE BRAIN [J].
GONG, CX ;
SINGH, TJ ;
GRUNDKEIQBAL, I ;
IQBAL, K .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (03) :921-927
[9]   NEURONAL ANTINUCLEAR ANTIBODY (ANTI-HU) IN PARA-NEOPLASTIC ENCEPHALOMYELITIS SIMULATING ACUTE POLYNEURITIS [J].
GRAUS, F ;
ELKON, KB ;
LLOBERES, P ;
RIBALTA, T ;
TORRES, A ;
USSETTI, P ;
VALLS, J ;
OBACH, J ;
AGUSTIVIDAL, A .
ACTA NEUROLOGICA SCANDINAVICA, 1987, 75 (04) :249-252
[10]   Anti-Hu immunolabeling as an index of neuronal differentiation in human brain tumors - A study of 112 central neuroepithelial neoplasms [J].
Gultekin, SH ;
Dalmau, J ;
Graus, Y ;
Posner, JB ;
Rosenblum, MK .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (02) :195-200